The world leader in bioprinting, Cellink, has opened a US headquarters in Boston, according to a report published by the BBC.

The Swedish firm, which was founded last year, became the first to sell bio-ink and 3D printers online. The firm racked up sales of US$1.5 million in its first year, and was listed on First North within 10 months of opening, valued at US$16.8 million.

The global bioprinting market is currently valued at US$411 million, according to Markets and Markets Research, and is predicted to reach US$1.33 billion by 2021.